These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 24853027)

  • 1. Antigenic peptide molecular recognition by the DRB1-DQB1 haplotype modulates multiple sclerosis susceptibility.
    Kumar A; Melis P; Genna V; Cocco E; Marrosu MG; Pieroni E
    Mol Biosyst; 2014 Aug; 10(8):2043-54. PubMed ID: 24853027
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DQB1*0602 rather than DRB1*1501 confers susceptibility to multiple sclerosis-like disease induced by proteolipid protein (PLP).
    Kaushansky N; Altmann DM; David CS; Lassmann H; Ben-Nun A
    J Neuroinflammation; 2012 Feb; 9():29. PubMed ID: 22316121
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interaction between HLA-DRB1-DQB1 haplotypes in Sardinian multiple sclerosis population.
    Cocco E; Murru R; Costa G; Kumar A; Pieroni E; Melis C; Barberini L; Sardu C; Lorefice L; Fenu G; Frau J; Coghe G; Carboni N; Marrosu MG
    PLoS One; 2013; 8(4):e59790. PubMed ID: 23593151
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HLA-DRB1-DQB1 haplotypes confer susceptibility and resistance to multiple sclerosis in Sardinia.
    Cocco E; Sardu C; Pieroni E; Valentini M; Murru R; Costa G; Tranquilli S; Frau J; Coghe G; Carboni N; Floris M; Contu P; Marrosu MG
    PLoS One; 2012; 7(4):e33972. PubMed ID: 22509268
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HLA-DQB1*0602 determines disease susceptibility in a new "humanized" multiple sclerosis model in HLA-DR15 (DRB1*1501;DQB1*0602) transgenic mice.
    Kaushansky N; Altmann DM; Ascough S; David CS; Lassmann H; Ben-Nun A
    J Immunol; 2009 Sep; 183(5):3531-41. PubMed ID: 19648275
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The association of HLA-DRB1 and HLA-DQB1 alleles with genetic susceptibility to multiple sclerosis in the Slovak population.
    Michalik J; Čierny D; Kantorová E; Kantárová D; Juraj J; Párnická Z; Kurča E; Dobrota D; Lehotský J
    Neurol Res; 2015; 37(12):1060-7. PubMed ID: 26744784
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HLA class II associated risk and protection against multiple sclerosis-a Finnish family study.
    Laaksonen M; Pastinen T; Sjöroos M; Kuokkanen S; Ruutiainen J; Sumelahti ML; Reijonen H; Salonen R; Wikström J; Panelius M; Partanen J; Tienari PJ; Ilonen J
    J Neuroimmunol; 2002 Jan; 122(1-2):140-5. PubMed ID: 11777553
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HLA-DRB1*1501, -DQB1*0301, -DQB1*0302, -DQB1*0602, and -DQB1*0603 alleles are associated with more severe disease outcome on MRI in patients with multiple sclerosis.
    Zivadinov R; Uxa L; Bratina A; Bosco A; Srinivasaraghavan B; Minagar A; Ukmar M; Benedetto Sy; Zorzon M
    Int Rev Neurobiol; 2007; 79():521-35. PubMed ID: 17531857
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of extended HLA haplotypes in multiple sclerosis and narcolepsy families confirms a predisposing effect for the class I region in Tasmanian MS patients.
    Rubio JP; Bahlo M; Stankovich J; Burfoot RK; Johnson LJ; Huxtable S; Butzkueven H; Lin L; Taylor BV; Speed TP; Kilpatrick TJ; Mignot E; Foote SJ
    Immunogenetics; 2007 Mar; 59(3):177-86. PubMed ID: 17256150
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic factors and multiple sclerosis in the Moroccan population: a role for HLA class II.
    Ouadghiri S; El Alaoui Toussi K; Brick C; Ait Benhaddou EH; Benseffaj N; Benomar A; El Yahyaoui M; Essakalli M
    Pathol Biol (Paris); 2013 Dec; 61(6):259-63. PubMed ID: 23849771
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Susceptibility alleles and haplotypes of human leukocyte antigen DRB1, DQA1, and DQB1 in autoimmune polyglandular syndrome type III in Japanese population.
    Hashimoto K; Maruyama H; Nishiyama M; Asaba K; Ikeda Y; Takao T; Iwasaki Y; Kumon Y; Suehiro T; Tanimoto N; Mizobuchi M; Nakamura T
    Horm Res; 2005; 64(5):253-60. PubMed ID: 16254435
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The influence of the HLA-DRB1 and HLA-DQB1 allele heterogeneity on disease risk and severity in Iranian patients with multiple sclerosis.
    Kollaee A; Ghaffarpor M; Ghlichnia HA; Ghaffari SH; Zamani M
    Int J Immunogenet; 2012 Oct; 39(5):414-22. PubMed ID: 22404765
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Involvement of HLA Class II Alleles in Multiple Sclerosis: A Systematic Review with Meta-analysis.
    De Silvestri A; Capittini C; Mallucci G; Bergamaschi R; Rebuffi C; Pasi A; Martinetti M; Tinelli C
    Dis Markers; 2019; 2019():1409069. PubMed ID: 31781296
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HLA associations with multiple sclerosis in Greece.
    Kouri I; Papakonstantinou S; Bempes V; Vasiliadis HS; Kyritsis AP; Pelidou SH
    J Neurol Sci; 2011 Sep; 308(1-2):28-31. PubMed ID: 21741664
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human leukocyte antigen class II molecules confer both susceptibility and progression in Japanese patients with primary biliary cirrhosis.
    Umemura T; Joshita S; Ichijo T; Yoshizawa K; Katsuyama Y; Tanaka E; Ota M;
    Hepatology; 2012 Feb; 55(2):506-11. PubMed ID: 21953406
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The HLA-B*39 allele increases type 1 diabetes risk conferred by HLA-DRB1*04:04-DQB1*03:02 and HLA-DRB1*08-DQB1*04 class II haplotypes.
    Mikk ML; Kiviniemi M; Laine AP; Härkönen T; Veijola R; Simell O; Knip M; Ilonen J;
    Hum Immunol; 2014 Jan; 75(1):65-70. PubMed ID: 24055898
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protective Allele for Multiple Sclerosis HLA-DRB1*01:01 Provides Kinetic Discrimination of Myelin and Exogenous Antigenic Peptides.
    Mamedov A; Vorobyeva N; Filimonova I; Zakharova M; Kiselev I; Bashinskaya V; Baulina N; Boyko A; Favorov A; Kulakova O; Ziganshin R; Smirnov I; Poroshina A; Shilovskiy I; Khaitov M; Sykulev Y; Favorova O; Vlassov V; Gabibov A; Belogurov A
    Front Immunol; 2019; 10():3088. PubMed ID: 32010139
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peptide motif for the rat MHC class II molecule RT1.Da: similarities to the multiple sclerosis-associated HLA-DRB1*1501 molecule.
    Duyar H; Dengjel J; de Graaf KL; Wiesmüller KH; Stevanović S; Weissert R
    Immunogenetics; 2005 Apr; 57(1-2):69-76. PubMed ID: 15711804
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DQB1*0602 allele shows a strong association with multiple sclerosis in patients in Malaga, Spain.
    Fernández O; Fernández V; Alonso A; Caballero A; Luque G; Bravo M; León A; Mayorga C; Leyva L; de Ramón E
    J Neurol; 2004 Apr; 251(4):440-4. PubMed ID: 15083289
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Opposing effects of the HLA-DRB1*0301-DQB1*0201 haplotype on the risk for multiple sclerosis in diverse Arab populations in Israel.
    Benedek G; Paperna T; Avidan N; Lejbkowicz I; Oksenberg JR; Wang J; Brautbar C; Israel S; Miller A;
    Genes Immun; 2010 Jul; 11(5):423-31. PubMed ID: 20463743
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.